|
OMIM |
Link |
Information gain |
01 |
|
HLP
|
[NCBI]
|
0.00544806
|
|
|
malignant atrophic papulosis
|
[NCBI]
|
0.00524042
|
|
|
PXE
|
[NCBI]
|
0.00429748
|
|
|
AKE
|
[NCBI]
|
0.00343241
|
|
|
comedones, familial dyskeratotic
|
[NCBI]
|
0.00261266
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.00242824
|
|
|
RA
|
[NCBI]
|
0.00214104
|
|
|
oculocerebral syndrome with hypopigmentation
|
[NCBI]
|
0.00211268
|
|
|
collagenosis, familial reactive perforating
|
[NCBI]
|
0.001867
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.001867
|
|
|
hyperpigmentation, familial progressive
|
[NCBI]
|
0.00174011
|
|
|
telangiectasia, hereditary benign
|
[NCBI]
|
0.00174011
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
0.001633
|
|
|
neutrophilic dermatosis, acute febrile
|
[NCBI]
|
0.00144847
|
|
|
epidermolysis bullosa inversa dystrophica
|
[NCBI]
|
0.00131639
|
|
|
sneddon syndrome
|
[NCBI]
|
0.00131639
|
|
|
sclerotylosis
|
[NCBI]
|
0.00131639
|
|
|
callosities, hereditary painful
|
[NCBI]
|
0.00131639
|
|
|
EBR1
|
[NCBI]
|
0.00130078
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00126431
|
|
|
IP
|
[NCBI]
|
0.00125374
|
|
|
BZX
|
[NCBI]
|
0.00120369
|
|
|
bullous dystrophy, hereditary macular type
|
[NCBI]
|
0.00112744
|
|
|
focal facial dermal dysplasia
|
[NCBI]
|
0.00112744
|
|
|
VRNI
|
[NCBI]
|
0.00110111
|
|
|
EV
|
[NCBI]
|
0.00106624
|
|
|
CF
|
[NCBI]
|
0.00101274
|
|
|
cutis laxa, corneal clouding, and mental retardation
|
[NCBI]
|
0.00099918
|
|
|
acromial dimples
|
[NCBI]
|
0.00099918
|
|
|
methylmalonic aciduria and homocystinuria, cbld type
|
[NCBI]
|
0.00099918
|
|
|
schopf-schulz-passarge syndrome
|
[NCBI]
|
0.00099918
|
|
|
LI1
|
[NCBI]
|
0.00099859
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
0.000967933
|
|
|
schimmelpenning-feuerstein-mims syndrome
|
[NCBI]
|
0.000901983
|
|
|
porokeratosis of mibelli
|
[NCBI]
|
0.000901983
|
|
|
actinic prurigo
|
[NCBI]
|
0.000869231
|
|
|
dermochondrocorneal dystrophy
|
[NCBI]
|
0.000869231
|
|
|
larsen-like syndrome
|
[NCBI]
|
0.000869231
|
|
|
flynn-aird syndrome
|
[NCBI]
|
0.000869231
|
|
|
erythrokeratodermia with ataxia
|
[NCBI]
|
0.000869231
|
|
|
tricarboxylic acid cycle, defect of
|
[NCBI]
|
0.000869231
|
|
|
striae distensae, familial
|
[NCBI]
|
0.000869231
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.00082758
|
|
|
AD
|
[NCBI]
|
0.00079201
|
|
|
LSA
|
[NCBI]
|
0.000739757
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
0.000721122
|
|
|
ehlers-danlos syndrome, type vib
|
[NCBI]
|
0.000703227
|
|
|
DDD
|
[NCBI]
|
0.000694705
|
|
|
TBDN
|
[NCBI]
|
0.00068681
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
0.000667235
|
|
|
CMTC
|
[NCBI]
|
0.000650506
|
|
|
MG
|
[NCBI]
|
0.000646014
|
|
|
tight skin contracture syndrome, lethal
|
[NCBI]
|
0.000629169
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
0.000617114
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
0.00060637
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
0.000602568
|
|
|
DFSP
|
[NCBI]
|
0.000581929
|
|
|
histidinemia
|
[NCBI]
|
0.000572184
|
|
|
dilution, pigmentary
|
[NCBI]
|
0.000562926
|
|
|
TRICY1
|
[NCBI]
|
0.000562926
|
|
|
SCAR5
|
[NCBI]
|
0.000562926
|
|
|
acanthosis nigricans
|
[NCBI]
|
0.000562926
|
|
|
PDR
|
[NCBI]
|
0.000562926
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
0.000553539
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
0.000537792
|
|
|
ehlers-danlos syndrome, type vii, autosomal dominant
|
[NCBI]
|
0.000508206
|
|
|
PCOS1
|
[NCBI]
|
0.000507968
|
|
|
PPSH
|
[NCBI]
|
0.000497657
|
|
|
SLS
|
[NCBI]
|
0.000475514
|
|
|
FGF7
|
[NCBI]
|
0.000472254
|
|
|
anencephaly
|
[NCBI]
|
0.000450234
|
|
|
hydroxykynureninuria
|
[NCBI]
|
0.000450234
|
|
|
ehlers-danlos syndrome, type v
|
[NCBI]
|
0.000450234
|
|
|
PPPP
|
[NCBI]
|
0.000450234
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000450234
|
|
|
letterer-siwe disease
|
[NCBI]
|
0.000450234
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
0.000446832
|
|
|
mucolipidosis iv
|
[NCBI]
|
0.000434757
|
|
|
cutis laxa, autosomal dominant
|
[NCBI]
|
0.000429038
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
0.000429038
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
0.000400377
|
|
|
AIS
|
[NCBI]
|
0.000395896
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
0.000384244
|
|
|
keratolytic winter erythema
|
[NCBI]
|
0.000378696
|
|
|
CGF
|
[NCBI]
|
0.000378696
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
0.000378696
|
|
|
frontofacionasal dysostosis
|
[NCBI]
|
0.000378696
|
|
|
ichthyosis follicularis, atrichia, and photophobia syndrome
|
[NCBI]
|
0.000378696
|
|
|
keratosis palmoplantaris papulosa
|
[NCBI]
|
0.000378696
|
|
|
EPPK
|
[NCBI]
|
0.000378411
|
|
|
GABEB
|
[NCBI]
|
0.000369494
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000369043
|
|
|
ALD
|
[NCBI]
|
0.000368638
|
|
|
NCIE1
|
[NCBI]
|
0.000358383
|
|
|
CJD
|
[NCBI]
|
0.00034155
|
|
|
COL7A1
|
[NCBI]
|
0.000329781
|
|
|
EGF
|
[NCBI]
|
0.000326958
|
|
|
cataract and cardiomyopathy
|
[NCBI]
|
0.000326704
|
|
|
CLN4A
|
[NCBI]
|
0.000326704
|
|
|
acromegaloid facial appearance syndrome
|
[NCBI]
|
0.000326704
|
|
|
nevi flammei, familial multiple
|
[NCBI]
|
0.000326704
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
0.000319938
|
|
|
FDH
|
[NCBI]
|
0.000319938
|
|
|
PD
|
[NCBI]
|
0.000313479
|
|
|
FCAS
|
[NCBI]
|
0.000310727
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
0.000310727
|
|
|
BCPM
|
[NCBI]
|
0.000304154
|
|
|
CRC
|
[NCBI]
|
0.000299047
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
0.000294244
|
|
|
ehlers-danlos-like syndrome due to tenascin-x deficiency
|
[NCBI]
|
0.000294244
|
|
|
CYP1A1
|
[NCBI]
|
0.000289436
|
|
|
progeroid syndrome, neonatal
|
[NCBI]
|
0.000286226
|
|
|
dermatitis, atopic
|
[NCBI]
|
0.000286226
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.000286226
|
|
|
ichthyosis, bullous type
|
[NCBI]
|
0.000285959
|
|
|
epidermolysis bullosa herpetiformis, dowling-meara type
|
[NCBI]
|
0.000285959
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
0.000281165
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000267034
|
|
|
omenn syndrome
|
[NCBI]
|
0.000265882
|
|
|
EKV
|
[NCBI]
|
0.000264627
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
0.000259625
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
0.000259625
|
|
|
AUTS4
|
[NCBI]
|
0.000253355
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000253355
|
|
|
CLN4B
|
[NCBI]
|
0.000253355
|
|
|
PSORS4
|
[NCBI]
|
0.000253355
|
|
|
acetabular dysplasia
|
[NCBI]
|
0.000253355
|
|
|
MFS
|
[NCBI]
|
0.000251059
|
|
|
mast cell disease
|
[NCBI]
|
0.000238858
|
|
|
SLE
|
[NCBI]
|
0.000235177
|
|
|
fabry disease
|
[NCBI]
|
0.000234099
|
|
|
EBS-MP
|
[NCBI]
|
0.000231417
|
|
|
OCA3
|
[NCBI]
|
0.000231417
|
|
|
NETH
|
[NCBI]
|
0.000228994
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
0.00022589
|
|
|
CDB2
|
[NCBI]
|
0.00022589
|
|
|
IGES
|
[NCBI]
|
0.00022589
|
|
|
skin creases, multiple benign ring-shaped, of limbs
|
[NCBI]
|
0.00022589
|
|
|
COL17A1
|
[NCBI]
|
0.00022503
|
|
|
glycogen storage disease iv
|
[NCBI]
|
0.000222479
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000222324
|
|
|
TGM1
|
[NCBI]
|
0.000216861
|
|
|
EPS
|
[NCBI]
|
0.000209524
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
0.000209524
|
|
|
COL1A2
|
[NCBI]
|
0.000209025
|
|
|
PI3
|
[NCBI]
|
0.000208191
|
|
|
buschke-ollendorff syndrome
|
[NCBI]
|
0.000207089
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
0.00020247
|
|
|
ZLS
|
[NCBI]
|
0.00020247
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
0.000200888
|
|
|
hydroa vacciniforme, familial
|
[NCBI]
|
0.000196146
|
|
|
ichthyosis hystrix gravior
|
[NCBI]
|
0.000196146
|
|
|
toenail dystrophy, isolated
|
[NCBI]
|
0.000196146
|
|
|
urocanase deficiency
|
[NCBI]
|
0.000196146
|
|
|
NEPPK
|
[NCBI]
|
0.000196146
|
|
|
AMVC
|
[NCBI]
|
0.000196146
|
|
|
ichthyosis, cyclic, with epidermolytic hyperkeratosis
|
[NCBI]
|
0.000196146
|
|
|
neuraminidase deficiency
|
[NCBI]
|
0.000195955
|
|
|
hurler syndrome
|
[NCBI]
|
0.000195606
|
|
|
amyloidosis v
|
[NCBI]
|
0.000194386
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
0.00019286
|
|
|
KLK7
|
[NCBI]
|
0.000188568
|
|
|
PSORS1
|
[NCBI]
|
0.000186504
|
|
|
MTS
|
[NCBI]
|
0.000185364
|
|
|
TOC
|
[NCBI]
|
0.000182187
|
|
|
PSORS2
|
[NCBI]
|
0.000182187
|
|
|
kanzaki disease
|
[NCBI]
|
0.000179119
|
|
|
menkes disease
|
[NCBI]
|
0.000177158
|
|
|
CCK
|
[NCBI]
|
0.000176225
|
|
|
BHD
|
[NCBI]
|
0.000173132
|
|
|
CIPA
|
[NCBI]
|
0.000173132
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
0.000171743
|
|
|
FBN1
|
[NCBI]
|
0.000170499
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
0.000167117
|
|
|
CD
|
[NCBI]
|
0.00016676
|
|
|
HGPS
|
[NCBI]
|
0.00016612
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
0.000165522
|
|
|
facial ectodermal dysplasia
|
[NCBI]
|
0.000164412
|
|
|
WSS
|
[NCBI]
|
0.000162414
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
0.000162414
|
|
|
erythermalgia, primary
|
[NCBI]
|
0.000162414
|
|
|
kindler syndrome
|
[NCBI]
|
0.000162414
|
|
|
DAR
|
[NCBI]
|
0.000159645
|
|
|
POMC
|
[NCBI]
|
0.00015786
|
|
|
GFAP
|
[NCBI]
|
0.000156541
|
|
|
UCMD
|
[NCBI]
|
0.000155823
|
|
|
sjogren syndrome
|
[NCBI]
|
0.000148686
|
|
|
CTGF
|
[NCBI]
|
0.000147005
|
|
|
MDD
|
[NCBI]
|
0.000145233
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
0.000143885
|
|
|
COL1A1
|
[NCBI]
|
0.000143183
|
|
|
glomerulonephritis with sparse hair and telangiectases
|
[NCBI]
|
0.000142946
|
|
|
OCA1B
|
[NCBI]
|
0.000142946
|
|
|
epidermolysis bullosa with congenital localized absence of skin and deformity of nails
|
[NCBI]
|
0.000142946
|
|
|
zunich neuroectodermal syndrome
|
[NCBI]
|
0.000142946
|
|
|
COL3A1
|
[NCBI]
|
0.000139401
|
|
|
morquio syndrome b
|
[NCBI]
|
0.000137351
|
|
|
AS
|
[NCBI]
|
0.000136482
|
|
|
mucolipidosis ii
|
[NCBI]
|
0.000133143
|
|
|
LAMB3
|
[NCBI]
|
0.000132942
|
|
|
XPA
|
[NCBI]
|
0.000130061
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000129366
|
|
|
TSD
|
[NCBI]
|
0.000129335
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
0.00012884
|
|
|
PALS
|
[NCBI]
|
0.000127487
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
0.000127487
|
|
|
MSD
|
[NCBI]
|
0.000125889
|
|
|
CDPX2
|
[NCBI]
|
0.000125889
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
0.000124978
|
|
|
CHAT
|
[NCBI]
|
0.000122109
|
|
|
VEGF
|
[NCBI]
|
0.00012038
|
|
|
ichthyosiform erythroderma, corneal involvement, and deafness
|
[NCBI]
|
0.000119397
|
|
|
epidermolysis bullosa of hands and feet
|
[NCBI]
|
0.000119397
|
|
|
epidermolysis bullosa, pretibial
|
[NCBI]
|
0.000119397
|
|
|
PDP
|
[NCBI]
|
0.000118846
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
0.000117987
|
|
|
KRT14
|
[NCBI]
|
0.000117973
|
|
|
mannosidosis, beta a, lysosomal
|
[NCBI]
|
0.000111177
|
|
|
dubowitz syndrome
|
[NCBI]
|
0.000110753
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
0.00010841
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
0.00010841
|
|
|
ACHE
|
[NCBI]
|
0.00010631
|
|
|
BWS
|
[NCBI]
|
0.000105968
|
|
|
MBP
|
[NCBI]
|
0.000105608
|
|
|
CLN3
|
[NCBI]
|
0.000104176
|
|
|
indifference to pain, congenital, autosomal recessive
|
[NCBI]
|
0.000103513
|
|
|
IHCM
|
[NCBI]
|
0.000103513
|
|
|
lenz-majewski hyperostotic dwarfism
|
[NCBI]
|
0.000103513
|
|
|
ectodermal dysplasia/skin fragility syndrome
|
[NCBI]
|
0.000103513
|
|
|
winchester syndrome
|
[NCBI]
|
0.000103513
|
|
|
APC
|
[NCBI]
|
0.000102068
|
|
|
PWS
|
[NCBI]
|
0.000101552
|
|
|
NLS
|
[NCBI]
|
0.000100486
|
|
|
ACC
|
[NCBI]
|
0.000100486
|
|
|
PLOD1
|
[NCBI]
|
0.000100399
|
|
|
DCN
|
[NCBI]
|
9.95547e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
9.8076e-05
|
|
|
brain anomalies, retardation, ectodermal dysplasia, skeletal malformations, hirschsprung disease, ear/eye anomalies, cleft palate/cryptorchidism, and kidney dysplasia/hypoplasia
|
[NCBI]
|
9.80642e-05
|
|
|
gangliosidosis, gm2, juvenile, a(m)b variant
|
[NCBI]
|
9.80642e-05
|
|
|
ataxia-telangiectasia with generalized skin pigmentation and early death
|
[NCBI]
|
9.80642e-05
|
|
|
piebald trait with neurologic defects
|
[NCBI]
|
9.80642e-05
|
|
|
erythrokeratodermia, progressive symmetric
|
[NCBI]
|
9.80642e-05
|
|
|
melanoma, malignant familial intraocular
|
[NCBI]
|
9.80642e-05
|
|
|
macules, hereditary congenital hypopigmented and hyperpigmented
|
[NCBI]
|
9.80642e-05
|
|
|
hyperhidrosis palmaris et plantaris
|
[NCBI]
|
9.80642e-05
|
|
|
premature aging syndrome, penttinen type
|
[NCBI]
|
9.80642e-05
|
|
|
spondyloepiphyseal dysplasia with punctate corneal dystrophy
|
[NCBI]
|
9.80642e-05
|
|
|
nakajo syndrome
|
[NCBI]
|
9.80642e-05
|
|
|
mucopolysaccharidosis type viii
|
[NCBI]
|
9.80642e-05
|
|
|
nephropathy with pretibial epidermolysis bullosa and deafness
|
[NCBI]
|
9.80642e-05
|
|
|
oculocerebral hypopigmentation syndrome of preus
|
[NCBI]
|
9.80642e-05
|
|
|
woolly hair, autosomal recessive
|
[NCBI]
|
9.80642e-05
|
|
|
dermoodontodysplasia
|
[NCBI]
|
9.80642e-05
|
|
|
kyrle disease
|
[NCBI]
|
9.80642e-05
|
|
|
ehlers-danlos syndrome, autosomal recessive, cardiac valvular form
|
[NCBI]
|
9.80642e-05
|
|
|
CDG2D
|
[NCBI]
|
9.80642e-05
|
|
|
eccrine syringofibroadenomatosis with eyelid abnormalities
|
[NCBI]
|
9.80642e-05
|
|
|
epidermolysis bullosa, late-onset localized junctional, with mental retardation
|
[NCBI]
|
9.80642e-05
|
|
|
spondyloepimetaphyseal dysplasia, genevieve type
|
[NCBI]
|
9.80642e-05
|
|
|
skin fragility-woolly hair syndrome
|
[NCBI]
|
9.80642e-05
|
|
|
syringomas, multiple
|
[NCBI]
|
9.80642e-05
|
|
|
dermatoleukodystrophy
|
[NCBI]
|
9.80642e-05
|
|
|
methylmalonyl-coa epimerase deficiency
|
[NCBI]
|
9.80642e-05
|
|
|
pellagra-like syndrome
|
[NCBI]
|
9.80642e-05
|
|
|
parc syndrome
|
[NCBI]
|
9.80642e-05
|
|
|
metachromasia of fibroblasts
|
[NCBI]
|
9.80642e-05
|
|
|
thyroid hormone metabolism, abnormal
|
[NCBI]
|
9.80642e-05
|
|
|
COFS4
|
[NCBI]
|
9.80642e-05
|
|
|
ichthyosis, mental retardation, dwarfism, and renal impairment
|
[NCBI]
|
9.80642e-05
|
|
|
bird-headed dwarfism, montreal type
|
[NCBI]
|
9.80642e-05
|
|
|
paget disease, extramammary
|
[NCBI]
|
9.80642e-05
|
|
|
porokeratosis plantaris, palmaris, et disseminata
|
[NCBI]
|
9.80642e-05
|
|
|
epidermolysis bullosa simplex, autosomal recessive
|
[NCBI]
|
9.80642e-05
|
|
|
vasculitis, lymphocytic, nodular
|
[NCBI]
|
9.80642e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
9.80642e-05
|
|
|
angiokeratoma corporis diffusum with arteriovenous fistulas
|
[NCBI]
|
9.80642e-05
|
|
|
rombo syndrome
|
[NCBI]
|
9.80642e-05
|
|
|
pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency
|
[NCBI]
|
9.80642e-05
|
|
|
keratoses, familial actinic
|
[NCBI]
|
9.80642e-05
|
|
|
xeroderma pigmentosum, autosomal dominant, mild
|
[NCBI]
|
9.80642e-05
|
|
|
ichthyosis-mental retardation syndrome with large keratohyalin granules in the skin
|
[NCBI]
|
9.80642e-05
|
|
|
trichoepitheliomas, multiple desmoplastic
|
[NCBI]
|
9.80642e-05
|
|
|
PUPPP
|
[NCBI]
|
9.80642e-05
|
|
|
CDG1M
|
[NCBI]
|
9.80642e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
9.24076e-05
|
|
|
MC1R
|
[NCBI]
|
9.17442e-05
|
|
|
XPG
|
[NCBI]
|
9.15526e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
9.15526e-05
|
|
|
DSAP1
|
[NCBI]
|
9.15526e-05
|
|
|
elejalde disease
|
[NCBI]
|
9.15526e-05
|
|
|
LOR
|
[NCBI]
|
8.80614e-05
|
|
|
CDS
|
[NCBI]
|
8.72128e-05
|
|
|
EPO
|
[NCBI]
|
8.62303e-05
|
|
|
NGFB
|
[NCBI]
|
8.61441e-05
|
|
|
KFSD
|
[NCBI]
|
8.24277e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
8.24277e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
8.20064e-05
|
|
|
schindler disease, type i
|
[NCBI]
|
8.20064e-05
|
|
|
ALUNC
|
[NCBI]
|
8.20064e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
8.20064e-05
|
|
|
fucosidosis
|
[NCBI]
|
8.12263e-05
|
|
|
NPC1
|
[NCBI]
|
8.06125e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
7.89656e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
7.83176e-05
|
|
|
AR
|
[NCBI]
|
7.76836e-05
|
|
|
TH
|
[NCBI]
|
7.7548e-05
|
|
|
ED1
|
[NCBI]
|
7.70879e-05
|
|
|
KRT10
|
[NCBI]
|
7.67925e-05
|
|
|
ZS
|
[NCBI]
|
7.65524e-05
|
|
|
ITGB4
|
[NCBI]
|
7.63033e-05
|
|
|
fibromatosis, juvenile hyaline
|
[NCBI]
|
7.41038e-05
|
|
|
PRL
|
[NCBI]
|
7.39545e-05
|
|
|
CCL27
|
[NCBI]
|
7.34299e-05
|
|
|
COL5A1
|
[NCBI]
|
7.34299e-05
|
|
|
KRT5
|
[NCBI]
|
7.08589e-05
|
|
|
MADA
|
[NCBI]
|
7.0057e-05
|
|
|
ABCC6
|
[NCBI]
|
6.92312e-05
|
|
|
PCNA
|
[NCBI]
|
6.91085e-05
|
|
|
CSA
|
[NCBI]
|
6.79106e-05
|
|
|
LMS
|
[NCBI]
|
6.73945e-05
|
|
|
MJD
|
[NCBI]
|
6.55483e-05
|
|
|
sandhoff disease
|
[NCBI]
|
6.54256e-05
|
|
|
ECM1
|
[NCBI]
|
6.53231e-05
|
|
|
KRT16
|
[NCBI]
|
6.38473e-05
|
|
|
KRT6A
|
[NCBI]
|
6.38473e-05
|
|
|
KRT2A
|
[NCBI]
|
6.38473e-05
|
|
|
PSAP
|
[NCBI]
|
6.35145e-05
|
|
|
porphyria variegata
|
[NCBI]
|
6.30391e-05
|
|
|
GBA
|
[NCBI]
|
6.25915e-05
|
|
|
SCEL
|
[NCBI]
|
6.23384e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
6.15921e-05
|
|
|
EBS2
|
[NCBI]
|
6.15921e-05
|
|
|
proteus syndrome
|
[NCBI]
|
6.12579e-05
|
|
|
TNXB
|
[NCBI]
|
6.10377e-05
|
|
|
WRN
|
[NCBI]
|
6.08628e-05
|
|
|
CFTR
|
[NCBI]
|
6.06782e-05
|
|
|
OODD
|
[NCBI]
|
5.96903e-05
|
|
|
hypospadias, x-linked
|
[NCBI]
|
5.96903e-05
|
|
|
sarcosinemia
|
[NCBI]
|
5.96903e-05
|
|
|
vohwinkel syndrome, variant form
|
[NCBI]
|
5.96903e-05
|
|
|
GPHN
|
[NCBI]
|
5.96903e-05
|
|
|
OCA4
|
[NCBI]
|
5.96903e-05
|
|
|
trichodiscomas, familial multiple
|
[NCBI]
|
5.96903e-05
|
|
|
colchicine resistance
|
[NCBI]
|
5.96903e-05
|
|
|
yemenite deaf-blind hypopigmentation syndrome
|
[NCBI]
|
5.96903e-05
|
|
|
epidermolysis bullosa with deficiency of galactosylhydroxylysyl glucosyltransferase
|
[NCBI]
|
5.96903e-05
|
|
|
EBDSC
|
[NCBI]
|
5.96903e-05
|
|
|
alpha-2-deficient collagen disease
|
[NCBI]
|
5.96903e-05
|
|
|
OASD
|
[NCBI]
|
5.96903e-05
|
|
|
urticaria, aquagenic
|
[NCBI]
|
5.96903e-05
|
|
|
ATOD4
|
[NCBI]
|
5.96903e-05
|
|
|
velofacioskeletal syndrome
|
[NCBI]
|
5.96903e-05
|
|
|
hyaluronan metabolism, defect in
|
[NCBI]
|
5.96903e-05
|
|
|
cardiomyopathy-hypogonadism-collagenoma syndrome
|
[NCBI]
|
5.96903e-05
|
|
|
CDG1C
|
[NCBI]
|
5.96903e-05
|
|
|
ichthyosis, follicular atrophoderma, hypotrichosis, and hypohidrosis
|
[NCBI]
|
5.96903e-05
|
|
|
dermatitis herpetiformis, familial
|
[NCBI]
|
5.96903e-05
|
|
|
cafe-au-lait spots, multiple
|
[NCBI]
|
5.96903e-05
|
|
|
hexokinase of spermatozoa
|
[NCBI]
|
5.96903e-05
|
|
|
optic atrophy 1 and deafness
|
[NCBI]
|
5.96903e-05
|
|
|
intrauterine growth retardation with increased mitomycin c sensitivity
|
[NCBI]
|
5.96903e-05
|
|
|
hypercholesterolemia, autosomal dominant, type b
|
[NCBI]
|
5.96903e-05
|
|
|
HDC
|
[NCBI]
|
5.94783e-05
|
|
|
CCHCR1
|
[NCBI]
|
5.94672e-05
|
|
|
EDAR
|
[NCBI]
|
5.94672e-05
|
|
|
CCL2
|
[NCBI]
|
5.84241e-05
|
|
|
ACADVL
|
[NCBI]
|
5.7359e-05
|
|
|
ATS
|
[NCBI]
|
5.65025e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
5.65025e-05
|
|
|
leopard syndrome 1
|
[NCBI]
|
5.65025e-05
|
|
|
scheie syndrome
|
[NCBI]
|
5.65025e-05
|
|
|
KRT15
|
[NCBI]
|
5.58744e-05
|
|
|
PLEC1
|
[NCBI]
|
5.58744e-05
|
|
|
XPC
|
[NCBI]
|
5.41412e-05
|
|
|
ATP2A2
|
[NCBI]
|
5.41412e-05
|
|
|
COL5A2
|
[NCBI]
|
5.28292e-05
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
5.28292e-05
|
|
|
GNRH1
|
[NCBI]
|
5.21456e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
5.19883e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
5.19883e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
5.13834e-05
|
|
|
LOX
|
[NCBI]
|
5.04339e-05
|
|
|
SPINK5
|
[NCBI]
|
5.0188e-05
|
|
|
DMD
|
[NCBI]
|
4.99995e-05
|
|
|
LAMC2
|
[NCBI]
|
4.8682e-05
|
|
|
NPPA
|
[NCBI]
|
4.83733e-05
|
|
|
AFP
|
[NCBI]
|
4.79877e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
4.79483e-05
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
4.79483e-05
|
|
|
propionic acidemia
|
[NCBI]
|
4.79483e-05
|
|
|
mucopolysaccharidoses, unclassified types
|
[NCBI]
|
4.57688e-05
|
|
|
pachydermodactyly, familial
|
[NCBI]
|
4.57688e-05
|
|
|
langerhans cell histiocytosis
|
[NCBI]
|
4.57688e-05
|
|
|
myeloma, multiple
|
[NCBI]
|
4.57688e-05
|
|
|
keratitis, hereditary
|
[NCBI]
|
4.57688e-05
|
|
|
acrogeria, gottron type
|
[NCBI]
|
4.57688e-05
|
|
|
keratosis pilaris
|
[NCBI]
|
4.57688e-05
|
|
|
barber-say syndrome
|
[NCBI]
|
4.57688e-05
|
|
|
raph blood group system
|
[NCBI]
|
4.57688e-05
|
|
|
lathosterolosis
|
[NCBI]
|
4.57688e-05
|
|
|
nevus, epidermal, epidermolytic hyperkeratotic type
|
[NCBI]
|
4.57688e-05
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
4.57688e-05
|
|
|
angioma serpiginosum, autosomal dominant
|
[NCBI]
|
4.57688e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
4.57688e-05
|
|
|
ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis
|
[NCBI]
|
4.57688e-05
|
|
|
amyloidosis, cerebroarterial, hereditary, iowa type
|
[NCBI]
|
4.57688e-05
|
|
|
brunner syndrome
|
[NCBI]
|
4.57688e-05
|
|
|
marfanoid hypermobility syndrome
|
[NCBI]
|
4.57688e-05
|
|
|
malonyl-coa decarboxylase deficiency
|
[NCBI]
|
4.57688e-05
|
|
|
polyposis, skin pigmentation, alopecia, and fingernail changes
|
[NCBI]
|
4.57688e-05
|
|
|
combined saposin deficiency
|
[NCBI]
|
4.57688e-05
|
|
|
lissencephaly type iii and bone dysplasia
|
[NCBI]
|
4.57688e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
4.53182e-05
|
|
|
PTK2
|
[NCBI]
|
4.52966e-05
|
|
|
BDNF
|
[NCBI]
|
4.48828e-05
|
|
|
CADASIL
|
[NCBI]
|
4.44357e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
4.4306e-05
|
|
|
DSG1
|
[NCBI]
|
4.42816e-05
|
|
|
CCL17
|
[NCBI]
|
4.40918e-05
|
|
|
KRT1
|
[NCBI]
|
4.38923e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
4.35575e-05
|
|
|
NS1
|
[NCBI]
|
4.35575e-05
|
|
|
DCT
|
[NCBI]
|
4.31068e-05
|
|
|
GPR2
|
[NCBI]
|
4.25622e-05
|
|
|
COL14A1
|
[NCBI]
|
4.25622e-05
|
|
|
ATP2C1
|
[NCBI]
|
4.25622e-05
|
|
|
ITGA6
|
[NCBI]
|
4.25622e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
4.25095e-05
|
|
|
ADCYAP1
|
[NCBI]
|
4.24844e-05
|
|
|
HMI
|
[NCBI]
|
4.2334e-05
|
|
|
BLM
|
[NCBI]
|
4.19676e-05
|
|
|
HEXA
|
[NCBI]
|
4.18114e-05
|
|
|
AEZ
|
[NCBI]
|
4.1002e-05
|
|
|
HPS
|
[NCBI]
|
4.04736e-05
|
|
|
DRPLA
|
[NCBI]
|
3.98463e-05
|
|
|
TS
|
[NCBI]
|
3.91942e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
3.89465e-05
|
|
|
PTH
|
[NCBI]
|
3.86223e-05
|
|
|
LAMA3
|
[NCBI]
|
3.83911e-05
|
|
|
SLC27A4
|
[NCBI]
|
3.83911e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
3.79894e-05
|
|
|
FSHMD1A
|
[NCBI]
|
3.79472e-05
|
|
|
PCCB
|
[NCBI]
|
3.77979e-05
|
|
|
LNS
|
[NCBI]
|
3.75109e-05
|
|
|
TYR
|
[NCBI]
|
3.71772e-05
|
|
|
cleft, median, of upper lip with polyps of facial skin and nasal mucosa
|
[NCBI]
|
3.70449e-05
|
|
|
leigh syndrome, x-linked
|
[NCBI]
|
3.70449e-05
|
|
|
3-@hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
3.70449e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
3.70449e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
3.70449e-05
|
|
|
vitiligo
|
[NCBI]
|
3.70449e-05
|
|
|
acyl-coa dehydrogenase, long-chain, deficiency of
|
[NCBI]
|
3.70449e-05
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
3.70449e-05
|
|
|
UVS
|
[NCBI]
|
3.70449e-05
|
|
|
achondroplasia, so-called, and severe combined immunodeficiency
|
[NCBI]
|
3.70449e-05
|
|
|
knuckle pads, leukonychia, and sensorineural deafness
|
[NCBI]
|
3.70449e-05
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
3.70449e-05
|
|
|
ABCD1
|
[NCBI]
|
3.66514e-05
|
|
|
CDSN
|
[NCBI]
|
3.65388e-05
|
|
|
DSP
|
[NCBI]
|
3.53598e-05
|
|
|
EDA
|
[NCBI]
|
3.53598e-05
|
|
|
EDC
|
[NCBI]
|
3.52303e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
3.52303e-05
|
|
|
TWIST2
|
[NCBI]
|
3.52169e-05
|
|
|
SPAG9
|
[NCBI]
|
3.52169e-05
|
|
|
SRD5A2
|
[NCBI]
|
3.52169e-05
|
|
|
CST6
|
[NCBI]
|
3.52169e-05
|
|
|
RARRES2
|
[NCBI]
|
3.52169e-05
|
|
|
ALOX12B
|
[NCBI]
|
3.52169e-05
|
|
|
DEFB103A
|
[NCBI]
|
3.52169e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
3.51546e-05
|
|
|
AHO
|
[NCBI]
|
3.47799e-05
|
|
|
SHH
|
[NCBI]
|
3.47723e-05
|
|
|
BGN
|
[NCBI]
|
3.44813e-05
|
|
|
TNC
|
[NCBI]
|
3.42715e-05
|
|
|
TF
|
[NCBI]
|
3.37757e-05
|
|
|
CNTF
|
[NCBI]
|
3.36257e-05
|
|
|
SLPI
|
[NCBI]
|
3.33574e-05
|
|
|
IL2
|
[NCBI]
|
3.31914e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
3.2694e-05
|
|
|
mucolipidosis iiia
|
[NCBI]
|
3.2694e-05
|
|
|
S100A7
|
[NCBI]
|
3.26565e-05
|
|
|
BCKDHA
|
[NCBI]
|
3.26565e-05
|
|
|
wolman disease
|
[NCBI]
|
3.25771e-05
|
|
|
TG
|
[NCBI]
|
3.2557e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
3.1465e-05
|
|
|
ALDH3A2
|
[NCBI]
|
3.12857e-05
|
|
|
ZAKI4
|
[NCBI]
|
3.11678e-05
|
|
|
p53-regulated apoptosis-inducing protein 1
|
[NCBI]
|
3.11678e-05
|
|
|
CAPN12
|
[NCBI]
|
3.11678e-05
|
|
|
PGLYRP3
|
[NCBI]
|
3.11678e-05
|
|
|
DEGS2
|
[NCBI]
|
3.11678e-05
|
|
|
FBS1
|
[NCBI]
|
3.11678e-05
|
|
|
skin-, embryo-, brain-, and oocyte-specific homeobox
|
[NCBI]
|
3.11678e-05
|
|
|
ONECUT2
|
[NCBI]
|
3.11678e-05
|
|
|
hairy palms and soles
|
[NCBI]
|
3.11678e-05
|
|
|
PGLYRP4
|
[NCBI]
|
3.11678e-05
|
|
|
ASCL4
|
[NCBI]
|
3.11678e-05
|
|
|
XDH
|
[NCBI]
|
3.11563e-05
|
|
|
DSG3
|
[NCBI]
|
3.0828e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
3.07895e-05
|
|
|
CPAF
|
[NCBI]
|
3.07895e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
3.07895e-05
|
|
|
ehlers-danlos syndrome, type iii
|
[NCBI]
|
3.07895e-05
|
|
|
pyruvate dehydrogenase phosphatase deficiency
|
[NCBI]
|
3.07895e-05
|
|
|
cerebellotrigeminal dermal dysplasia
|
[NCBI]
|
3.07895e-05
|
|
|
MTC
|
[NCBI]
|
3.07895e-05
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
3.07895e-05
|
|
|
CLPED1
|
[NCBI]
|
3.07895e-05
|
|
|
ehlers-danlos syndrome, progeroid form
|
[NCBI]
|
3.07895e-05
|
|
|
reifenstein syndrome
|
[NCBI]
|
3.07895e-05
|
|
|
glycogen storage disease 0, liver
|
[NCBI]
|
3.07895e-05
|
|
|
DPR
|
[NCBI]
|
3.07895e-05
|
|
|
ENTPD1
|
[NCBI]
|
3.05139e-05
|
|
|
PHYH
|
[NCBI]
|
3.05139e-05
|
|
|
FOXN1
|
[NCBI]
|
3.05139e-05
|
|
|
NOTCH3
|
[NCBI]
|
3.05139e-05
|
|
|
KRT9
|
[NCBI]
|
3.05139e-05
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
3.03547e-05
|
|
|
MUC1
|
[NCBI]
|
2.99607e-05
|
|
|
ARSB
|
[NCBI]
|
2.95523e-05
|
|
|
TYMS
|
[NCBI]
|
2.9545e-05
|
|
|
CYR61
|
[NCBI]
|
2.86746e-05
|
|
|
GALE
|
[NCBI]
|
2.86746e-05
|
|
|
PYY
|
[NCBI]
|
2.8559e-05
|
|
|
GPS
|
[NCBI]
|
2.8291e-05
|
|
|
EEC1
|
[NCBI]
|
2.8291e-05
|
|
|
CMM
|
[NCBI]
|
2.8291e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
2.81911e-05
|
|
|
HFTC
|
[NCBI]
|
2.81911e-05
|
|
|
HAE
|
[NCBI]
|
2.81911e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
2.81911e-05
|
|
|
AVP
|
[NCBI]
|
2.77992e-05
|
|
|
PMD
|
[NCBI]
|
2.76891e-05
|
|
|
F3
|
[NCBI]
|
2.75355e-05
|
|
|
MAOA
|
[NCBI]
|
2.72415e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
2.70761e-05
|
|
|
SLC17A5
|
[NCBI]
|
2.70658e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.70658e-05
|
|
|
GRIP1
|
[NCBI]
|
2.70658e-05
|
|
|
TRPV1
|
[NCBI]
|
2.65602e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
2.61852e-05
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
2.59881e-05
|
|
|
HIDS
|
[NCBI]
|
2.59881e-05
|
|
|
schwannomatosis
|
[NCBI]
|
2.59881e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
2.59881e-05
|
|
|
GGM
|
[NCBI]
|
2.59881e-05
|
|
|
gaucher disease, atypical, due to saposin c deficiency
|
[NCBI]
|
2.59881e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
2.59881e-05
|
|
|
lymphedema, hereditary, ii
|
[NCBI]
|
2.59881e-05
|
|
|
lactic acidosis, fatal infantile
|
[NCBI]
|
2.59881e-05
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
2.59881e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
2.59881e-05
|
|
|
ALS4
|
[NCBI]
|
2.59881e-05
|
|
|
adult syndrome
|
[NCBI]
|
2.59881e-05
|
|
|
PBT
|
[NCBI]
|
2.59881e-05
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
2.59881e-05
|
|
|
OPPG
|
[NCBI]
|
2.59881e-05
|
|
|
mitochondrial complex iii deficiency
|
[NCBI]
|
2.59881e-05
|
|
|
CYP19A1
|
[NCBI]
|
2.58809e-05
|
|
|
APOA1
|
[NCBI]
|
2.58578e-05
|
|
|
DSC1
|
[NCBI]
|
2.56382e-05
|
|
|
IL23A
|
[NCBI]
|
2.56382e-05
|
|
|
CD151
|
[NCBI]
|
2.56382e-05
|
|
|
B4GALT1
|
[NCBI]
|
2.56382e-05
|
|
|
CPT2
|
[NCBI]
|
2.56382e-05
|
|
|
ASIP
|
[NCBI]
|
2.56382e-05
|
|
|
TGFB1
|
[NCBI]
|
2.54476e-05
|
|
|
FA
|
[NCBI]
|
2.53156e-05
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
2.49866e-05
|
|
|
krabbe disease
|
[NCBI]
|
2.47925e-05
|
|
|
AEBP1
|
[NCBI]
|
2.43568e-05
|
|
|
FLG
|
[NCBI]
|
2.43568e-05
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
2.43216e-05
|
|
|
BCNS
|
[NCBI]
|
2.38723e-05
|
|
|
NAGA
|
[NCBI]
|
2.3196e-05
|
|
|
HPRT1
|
[NCBI]
|
2.28154e-05
|
|
|
ACP5
|
[NCBI]
|
2.27084e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
2.25868e-05
|
|
|
CNC1
|
[NCBI]
|
2.25868e-05
|
|
|
FRAP1
|
[NCBI]
|
2.24937e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
2.21474e-05
|
|
|
nephrosialidosis
|
[NCBI]
|
2.21474e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
2.21474e-05
|
|
|
porphyria cutanea tarda, type i
|
[NCBI]
|
2.21474e-05
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
2.21474e-05
|
|
|
MFS2
|
[NCBI]
|
2.21474e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
2.21474e-05
|
|
|
LDS
|
[NCBI]
|
2.21474e-05
|
|
|
GS1
|
[NCBI]
|
2.21474e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
2.21474e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
2.21474e-05
|
|
|
SPR
|
[NCBI]
|
2.21363e-05
|
|
|
FGFR2
|
[NCBI]
|
2.19764e-05
|
|
|
CAPN13
|
[NCBI]
|
2.12798e-05
|
|
|
S5
|
[NCBI]
|
2.12798e-05
|
|
|
UBQLN2
|
[NCBI]
|
2.12798e-05
|
|
|
CALML5
|
[NCBI]
|
2.12798e-05
|
|
|
ichthyin
|
[NCBI]
|
2.12798e-05
|
|
|
ACAD8
|
[NCBI]
|
2.12798e-05
|
|
|
r binder protein
|
[NCBI]
|
2.12798e-05
|
|
|
RHBG
|
[NCBI]
|
2.12798e-05
|
|
|
NAB2
|
[NCBI]
|
2.12798e-05
|
|
|
PERP
|
[NCBI]
|
2.12798e-05
|
|
|
MLZE
|
[NCBI]
|
2.12798e-05
|
|
|
C6ORF15
|
[NCBI]
|
2.12798e-05
|
|
|
TRIM16
|
[NCBI]
|
2.12798e-05
|
|
|
AASS
|
[NCBI]
|
2.12798e-05
|
|
|
GSDML
|
[NCBI]
|
2.12798e-05
|
|
|
PRKCH
|
[NCBI]
|
2.12798e-05
|
|
|
MUTED
|
[NCBI]
|
2.12798e-05
|
|
|
CLMN
|
[NCBI]
|
2.12798e-05
|
|
|
GSDM1
|
[NCBI]
|
2.12798e-05
|
|
|
IL22RA1
|
[NCBI]
|
2.12798e-05
|
|
|
CNFN
|
[NCBI]
|
2.12798e-05
|
|
|
PECI
|
[NCBI]
|
2.12798e-05
|
|
|
ADAMTS14
|
[NCBI]
|
2.12798e-05
|
|
|
ACOT2
|
[NCBI]
|
2.12798e-05
|
|
|
HOXB13
|
[NCBI]
|
2.12798e-05
|
|
|
CAPN14
|
[NCBI]
|
2.12798e-05
|
|
|
FBXO11
|
[NCBI]
|
2.12798e-05
|
|
|
FBN3
|
[NCBI]
|
2.12798e-05
|
|
|
KRT6B
|
[NCBI]
|
2.12798e-05
|
|
|
CASP14
|
[NCBI]
|
2.12798e-05
|
|
|
RELB
|
[NCBI]
|
2.12798e-05
|
|
|
PDHA1
|
[NCBI]
|
2.12734e-05
|
|
|
SMAD3
|
[NCBI]
|
2.11625e-05
|
|
|
ANGPT1
|
[NCBI]
|
2.11625e-05
|
|
|
VDR
|
[NCBI]
|
2.1011e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
2.09695e-05
|
|
|
SOD2
|
[NCBI]
|
2.04272e-05
|
|
|
PTHLH
|
[NCBI]
|
2.00932e-05
|
|
|
OCP
|
[NCBI]
|
1.98792e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
1.94597e-05
|
|
|
GAN1
|
[NCBI]
|
1.94597e-05
|
|
|
CYP27B1
|
[NCBI]
|
1.94276e-05
|
|
|
CDA
|
[NCBI]
|
1.89896e-05
|
|
|
VMCM
|
[NCBI]
|
1.89896e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
1.89896e-05
|
|
|
ablepharon-macrostomia syndrome
|
[NCBI]
|
1.89896e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
1.89896e-05
|
|
|
GS2
|
[NCBI]
|
1.89896e-05
|
|
|
megalencephaly-cutis marmorata telangiectatica congenita
|
[NCBI]
|
1.89896e-05
|
|
|
APL
|
[NCBI]
|
1.89896e-05
|
|
|
leiomyomatosis, esophageal and vulval, with nephropathy
|
[NCBI]
|
1.89896e-05
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
1.89896e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
1.89896e-05
|
|
|
CYLD
|
[NCBI]
|
1.89896e-05
|
|
|
hyperlysinemia
|
[NCBI]
|
1.89896e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
1.89896e-05
|
|
|
XPV
|
[NCBI]
|
1.89896e-05
|
|
|
PJS
|
[NCBI]
|
1.88467e-05
|
|
|
LGALS3
|
[NCBI]
|
1.86489e-05
|
|
|
PGM3
|
[NCBI]
|
1.86489e-05
|
|
|
EBP
|
[NCBI]
|
1.86489e-05
|
|
|
DHFR
|
[NCBI]
|
1.85764e-05
|
|
|
ACADM
|
[NCBI]
|
1.84215e-05
|
|
|
NPY
|
[NCBI]
|
1.81968e-05
|
|
|
EGFR
|
[NCBI]
|
1.79713e-05
|
|
|
SLC22A5
|
[NCBI]
|
1.79204e-05
|
|
|
PPARD
|
[NCBI]
|
1.79204e-05
|
|
|
HSD17B4
|
[NCBI]
|
1.79204e-05
|
|
|
drg11, rat, homolog of
|
[NCBI]
|
1.76072e-05
|
|
|
PADI3
|
[NCBI]
|
1.76072e-05
|
|
|
LYPD3
|
[NCBI]
|
1.76072e-05
|
|
|
ATP1AL1
|
[NCBI]
|
1.76072e-05
|
|
|
PRRX2
|
[NCBI]
|
1.76072e-05
|
|
|
AIM1
|
[NCBI]
|
1.76072e-05
|
|
|
RSPO1
|
[NCBI]
|
1.76072e-05
|
|
|
ASCL3
|
[NCBI]
|
1.76072e-05
|
|
|
ISLR
|
[NCBI]
|
1.76072e-05
|
|
|
MMP28
|
[NCBI]
|
1.76072e-05
|
|
|
PADI2
|
[NCBI]
|
1.76072e-05
|
|
|
IL1F5
|
[NCBI]
|
1.76072e-05
|
|
|
TNFRSF19
|
[NCBI]
|
1.76072e-05
|
|
|
EFEMP2
|
[NCBI]
|
1.76072e-05
|
|
|
ANGPTL6
|
[NCBI]
|
1.76072e-05
|
|
|
TMEM15
|
[NCBI]
|
1.76072e-05
|
|
|
BARX2
|
[NCBI]
|
1.76072e-05
|
|
|
leukoregulin
|
[NCBI]
|
1.76072e-05
|
|
|
PGLYRP2
|
[NCBI]
|
1.76072e-05
|
|
|
PLDN
|
[NCBI]
|
1.76072e-05
|
|
|
LGALS7
|
[NCBI]
|
1.76072e-05
|
|
|
GJB4
|
[NCBI]
|
1.76072e-05
|
|
|
DUSP7
|
[NCBI]
|
1.76072e-05
|
|
|
ABCB5
|
[NCBI]
|
1.76072e-05
|
|
|
MIA
|
[NCBI]
|
1.76072e-05
|
|
|
TPD52L1
|
[NCBI]
|
1.76072e-05
|
|
|
RABGEF1
|
[NCBI]
|
1.76072e-05
|
|
|
keratin 6, hair follicle
|
[NCBI]
|
1.76072e-05
|
|
|
RHEB2
|
[NCBI]
|
1.76072e-05
|
|
|
PEX10
|
[NCBI]
|
1.76072e-05
|
|
|
IL22RA2
|
[NCBI]
|
1.76072e-05
|
|
|
IGFBP6
|
[NCBI]
|
1.76072e-05
|
|
|
MTSS1
|
[NCBI]
|
1.76072e-05
|
|
|
BNC2
|
[NCBI]
|
1.76072e-05
|
|
|
UQCRB
|
[NCBI]
|
1.76072e-05
|
|
|
TPSD1
|
[NCBI]
|
1.76072e-05
|
|
|
CNO
|
[NCBI]
|
1.76072e-05
|
|
|
MANBA
|
[NCBI]
|
1.76072e-05
|
|
|
SC5DL
|
[NCBI]
|
1.76072e-05
|
|
|
CART1
|
[NCBI]
|
1.76072e-05
|
|
|
DYM
|
[NCBI]
|
1.76072e-05
|
|
|
COX15
|
[NCBI]
|
1.76072e-05
|
|
|
ELOVL3
|
[NCBI]
|
1.76072e-05
|
|
|
DDT
|
[NCBI]
|
1.76072e-05
|
|
|
DCXR
|
[NCBI]
|
1.76072e-05
|
|
|
SLC6A19
|
[NCBI]
|
1.76072e-05
|
|
|
LDHA
|
[NCBI]
|
1.72365e-05
|
|
|
ALCAM
|
[NCBI]
|
1.72365e-05
|
|
|
SMPD1
|
[NCBI]
|
1.72365e-05
|
|
|
TP73L
|
[NCBI]
|
1.72365e-05
|
|
|
CRH
|
[NCBI]
|
1.68917e-05
|
|
|
LDLR
|
[NCBI]
|
1.67834e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.67282e-05
|
|
|
SPP1
|
[NCBI]
|
1.65488e-05
|
|
|
succinyl-coa:3-oxoacid coa transferase deficiency
|
[NCBI]
|
1.63423e-05
|
|
|
ARH
|
[NCBI]
|
1.63423e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
1.63423e-05
|
|
|
EEC3
|
[NCBI]
|
1.63423e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
1.63423e-05
|
|
|
CDB1
|
[NCBI]
|
1.63423e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
1.63423e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
1.63423e-05
|
|
|
CDL1
|
[NCBI]
|
1.63423e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
1.63423e-05
|
|
|
CLN5
|
[NCBI]
|
1.63423e-05
|
|
|
RHS
|
[NCBI]
|
1.63423e-05
|
|
|
XPF
|
[NCBI]
|
1.63423e-05
|
|
|
WT1
|
[NCBI]
|
1.60939e-05
|
|
|
SCD
|
[NCBI]
|
1.60164e-05
|
|
|
CD
|
[NCBI]
|
1.60118e-05
|
|
|
TYRP1
|
[NCBI]
|
1.5985e-05
|
|
|
UCN
|
[NCBI]
|
1.59474e-05
|
|
|
PRLR
|
[NCBI]
|
1.5771e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
1.5492e-05
|
|
|
HBEGF
|
[NCBI]
|
1.541e-05
|
|
|
CCL22
|
[NCBI]
|
1.52921e-05
|
|
|
ABCG8
|
[NCBI]
|
1.52557e-05
|
|
|
PEX26
|
[NCBI]
|
1.52557e-05
|
|
|
CD200R1
|
[NCBI]
|
1.52557e-05
|
|
|
PI13
|
[NCBI]
|
1.52557e-05
|
|
|
SCCA2
|
[NCBI]
|
1.52557e-05
|
|
|
NDUFS7
|
[NCBI]
|
1.52557e-05
|
|
|
MTTW
|
[NCBI]
|
1.52557e-05
|
|
|
PTGIS
|
[NCBI]
|
1.52557e-05
|
|
|
XYLT1
|
[NCBI]
|
1.52557e-05
|
|
|
ADRM1
|
[NCBI]
|
1.52557e-05
|
|
|
HAL
|
[NCBI]
|
1.52557e-05
|
|
|
thymic stromal lymphopoietin
|
[NCBI]
|
1.52557e-05
|
|
|
PLOD2
|
[NCBI]
|
1.52557e-05
|
|
|
NAB1
|
[NCBI]
|
1.52557e-05
|
|
|
HOXB8
|
[NCBI]
|
1.52557e-05
|
|
|
ALOXE3
|
[NCBI]
|
1.52557e-05
|
|
|
MMP1
|
[NCBI]
|
1.4865e-05
|
|
|
ERCC2
|
[NCBI]
|
1.4865e-05
|
|
|
TTR
|
[NCBI]
|
1.4662e-05
|
|
|
IDUA
|
[NCBI]
|
1.46341e-05
|
|
|
ERCC5
|
[NCBI]
|
1.43472e-05
|
|
|
GLA
|
[NCBI]
|
1.43472e-05
|
|
|
HHT
|
[NCBI]
|
1.43114e-05
|
|
|
NF1
|
[NCBI]
|
1.42178e-05
|
|
|
oculocerebrocutaneous syndrome
|
[NCBI]
|
1.40913e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
1.40913e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
1.40913e-05
|
|
|
GUSB
|
[NCBI]
|
1.37315e-05
|
|
|
CXCL6
|
[NCBI]
|
1.35317e-05
|
|
|
FLOT2
|
[NCBI]
|
1.35317e-05
|
|
|
AGPS
|
[NCBI]
|
1.35317e-05
|
|
|
BNC1
|
[NCBI]
|
1.35317e-05
|
|
|
RAET1E
|
[NCBI]
|
1.35317e-05
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
1.35317e-05
|
|
|
ANTXR2
|
[NCBI]
|
1.35317e-05
|
|
|
TGFA
|
[NCBI]
|
1.35317e-05
|
|
|
SLC39A4
|
[NCBI]
|
1.35317e-05
|
|
|
SPRR1A
|
[NCBI]
|
1.35317e-05
|
|
|
SLC25A15
|
[NCBI]
|
1.35317e-05
|
|
|
TPSB2
|
[NCBI]
|
1.35317e-05
|
|
|
AOX1
|
[NCBI]
|
1.35317e-05
|
|
|
DPT
|
[NCBI]
|
1.35317e-05
|
|
|
AGL
|
[NCBI]
|
1.35317e-05
|
|
|
EPIM
|
[NCBI]
|
1.35317e-05
|
|
|
CCBP2
|
[NCBI]
|
1.35317e-05
|
|
|
HNRNPK
|
[NCBI]
|
1.35317e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.35141e-05
|
|
|
GIP
|
[NCBI]
|
1.3192e-05
|
|
|
CD36
|
[NCBI]
|
1.31814e-05
|
|
|
ABP1
|
[NCBI]
|
1.30719e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
1.29484e-05
|
|
|
TERC
|
[NCBI]
|
1.29368e-05
|
|
|
AQP3
|
[NCBI]
|
1.29368e-05
|
|
|
EDNRB
|
[NCBI]
|
1.29368e-05
|
|
|
AHR
|
[NCBI]
|
1.27944e-05
|
|
|
NMU
|
[NCBI]
|
1.26461e-05
|
|
|
LPL
|
[NCBI]
|
1.25433e-05
|
|
|
GJB2
|
[NCBI]
|
1.25223e-05
|
|
|
PEPD
|
[NCBI]
|
1.25083e-05
|
|
|
SLC11A1
|
[NCBI]
|
1.25083e-05
|
|
|
CGD
|
[NCBI]
|
1.24428e-05
|
|
|
AHC
|
[NCBI]
|
1.22293e-05
|
|
|
KRTHA2
|
[NCBI]
|
1.21772e-05
|
|
|
PPP1R13L
|
[NCBI]
|
1.21772e-05
|
|
|
LTB
|
[NCBI]
|
1.21772e-05
|
|
|
FBLN5
|
[NCBI]
|
1.21772e-05
|
|
|
ESCO2
|
[NCBI]
|
1.21772e-05
|
|
|
SRD5A1
|
[NCBI]
|
1.21772e-05
|
|
|
SELPLG
|
[NCBI]
|
1.21772e-05
|
|
|
SLC9A3R1
|
[NCBI]
|
1.21772e-05
|
|
|
IL11RA
|
[NCBI]
|
1.21772e-05
|
|
|
leucine zipper- and sterile alpha motif-containing kinase
|
[NCBI]
|
1.21772e-05
|
|
|
ZBTB7B
|
[NCBI]
|
1.21772e-05
|
|
|
OGFR
|
[NCBI]
|
1.21772e-05
|
|
|
TNR
|
[NCBI]
|
1.21772e-05
|
|
|
TOP2B
|
[NCBI]
|
1.21772e-05
|
|
|
GLI2
|
[NCBI]
|
1.21772e-05
|
|
|
HAGH
|
[NCBI]
|
1.21772e-05
|
|
|
CNR2
|
[NCBI]
|
1.21772e-05
|
|
|
S100A11
|
[NCBI]
|
1.21772e-05
|
|
|
LOXL2
|
[NCBI]
|
1.21772e-05
|
|
|
MTTS1
|
[NCBI]
|
1.21772e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
1.21569e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
1.21569e-05
|
|
|
sialuria
|
[NCBI]
|
1.21569e-05
|
|
|
CDGG1
|
[NCBI]
|
1.21569e-05
|
|
|
canavan disease
|
[NCBI]
|
1.21569e-05
|
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects
|
[NCBI]
|
1.21569e-05
|
|
|
LADD
|
[NCBI]
|
1.21569e-05
|
|
|
IKBKG
|
[NCBI]
|
1.20983e-05
|
|
|
COL6A1
|
[NCBI]
|
1.20983e-05
|
|
|
FMF
|
[NCBI]
|
1.19649e-05
|
|
|
RNASE2
|
[NCBI]
|
1.19575e-05
|
|
|
CHUK
|
[NCBI]
|
1.17055e-05
|
|
|
OA1
|
[NCBI]
|
1.17055e-05
|
|
|
TFPI
|
[NCBI]
|
1.16651e-05
|
|
|
PLG
|
[NCBI]
|
1.15946e-05
|
|
|
TPO
|
[NCBI]
|
1.14498e-05
|
|
|
RCDP1
|
[NCBI]
|
1.1274e-05
|
|
|
ARNT
|
[NCBI]
|
1.11764e-05
|
|
|
CD1B
|
[NCBI]
|
1.1067e-05
|
|
|
SECISBP2
|
[NCBI]
|
1.1067e-05
|
|
|
SLC45A2
|
[NCBI]
|
1.1067e-05
|
|
|
KRT17
|
[NCBI]
|
1.1067e-05
|
|
|
PCK2
|
[NCBI]
|
1.1067e-05
|
|
|
DCLRE1C
|
[NCBI]
|
1.1067e-05
|
|
|
RARRES1
|
[NCBI]
|
1.1067e-05
|
|
|
IRF6
|
[NCBI]
|
1.1067e-05
|
|
|
MC5R
|
[NCBI]
|
1.1067e-05
|
|
|
IL22
|
[NCBI]
|
1.1067e-05
|
|
|
CCL7
|
[NCBI]
|
1.1067e-05
|
|
|
LUM
|
[NCBI]
|
1.1067e-05
|
|
|
HYOU1
|
[NCBI]
|
1.1067e-05
|
|
|
CCL20
|
[NCBI]
|
1.1067e-05
|
|
|
SUFU
|
[NCBI]
|
1.1067e-05
|
|
|
NSDHL
|
[NCBI]
|
1.1067e-05
|
|
|
GREM1
|
[NCBI]
|
1.1067e-05
|
|
|
LOXL1
|
[NCBI]
|
1.1067e-05
|
|
|
CACNA1H
|
[NCBI]
|
1.1067e-05
|
|
|
GAB1
|
[NCBI]
|
1.1067e-05
|
|
|
CUL3
|
[NCBI]
|
1.1067e-05
|
|
|
GAN
|
[NCBI]
|
1.1067e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.09668e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.07227e-05
|
|
|
metachromatic leukodystrophy due to saposin b deficiency
|
[NCBI]
|
1.04812e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
1.04812e-05
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
1.04812e-05
|
|
|
sitosterolemia
|
[NCBI]
|
1.04812e-05
|
|
|
CMT4A
|
[NCBI]
|
1.04812e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
1.04812e-05
|
|
|
HSAN2
|
[NCBI]
|
1.04812e-05
|
|
|
DMC
|
[NCBI]
|
1.04812e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
1.04812e-05
|
|
|
CMT2A1
|
[NCBI]
|
1.04812e-05
|
|
|
polycythemia vera
|
[NCBI]
|
1.04812e-05
|
|
|
NGFR
|
[NCBI]
|
1.03068e-05
|
|
|
KSS
|
[NCBI]
|
1.01542e-05
|
|
|
TPSAB1
|
[NCBI]
|
1.01303e-05
|
|
|
ZMPSTE24
|
[NCBI]
|
1.01303e-05
|
|
|
HR
|
[NCBI]
|
1.01303e-05
|
|
|
MAP2K2
|
[NCBI]
|
1.01303e-05
|
|
|
PAI2
|
[NCBI]
|
1.01303e-05
|
|
|
DUSP6
|
[NCBI]
|
1.01303e-05
|
|
|
GGCX
|
[NCBI]
|
1.01303e-05
|
|
|
UBQLN1
|
[NCBI]
|
1.01303e-05
|
|
|
COL15A1
|
[NCBI]
|
1.01303e-05
|
|
|
NTS
|
[NCBI]
|
1.01303e-05
|
|
|
HLCS
|
[NCBI]
|
1.01303e-05
|
|
|
BLMH
|
[NCBI]
|
1.01303e-05
|
|
|
CSPG2
|
[NCBI]
|
1.01303e-05
|
|
|
ERRFI1
|
[NCBI]
|
1.01303e-05
|
|
|
MLYCD
|
[NCBI]
|
1.01303e-05
|
|
|
HYAL2
|
[NCBI]
|
1.01303e-05
|
|
|
LAMB1
|
[NCBI]
|
1.01303e-05
|
|
|
MAS
|
[NCBI]
|
1.00039e-05
|
|
|
ACCN2
|
[NCBI]
|
9.96259e-06
|
|
|
MAG
|
[NCBI]
|
9.74893e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
9.65235e-06
|
|
|
CCR6
|
[NCBI]
|
9.32338e-06
|
|
|
CCR7
|
[NCBI]
|
9.32338e-06
|
|
|
IL1RL1
|
[NCBI]
|
9.32338e-06
|
|
|
glutathionuria
|
[NCBI]
|
9.32338e-06
|
|
|
TNFAIP3
|
[NCBI]
|
9.32338e-06
|
|
|
SAA2
|
[NCBI]
|
9.32338e-06
|
|
|
IL2RB
|
[NCBI]
|
9.32338e-06
|
|
|
CMKLR1
|
[NCBI]
|
9.32338e-06
|
|
|
PTGER4
|
[NCBI]
|
9.32338e-06
|
|
|
CCL11
|
[NCBI]
|
9.32338e-06
|
|
|
CLC
|
[NCBI]
|
9.32338e-06
|
|
|
PXN
|
[NCBI]
|
9.32338e-06
|
|
|
PEX13
|
[NCBI]
|
9.32338e-06
|
|
|
AKT2
|
[NCBI]
|
9.32338e-06
|
|
|
DSG4
|
[NCBI]
|
9.32338e-06
|
|
|
OAS1
|
[NCBI]
|
9.32338e-06
|
|
|
ATOH1
|
[NCBI]
|
9.32338e-06
|
|
|
SFN
|
[NCBI]
|
9.32338e-06
|
|
|
VHL
|
[NCBI]
|
9.07334e-06
|
|
|
EDN1
|
[NCBI]
|
9.06467e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
9.06467e-06
|
|
|
RBP1
|
[NCBI]
|
9.03801e-06
|
|
|
CLN2
|
[NCBI]
|
9.02105e-06
|
|
|
BFLS
|
[NCBI]
|
9.02105e-06
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
9.02105e-06
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
9.02105e-06
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
9.02105e-06
|
|
|
ED2
|
[NCBI]
|
9.02105e-06
|
|
|
RASA1
|
[NCBI]
|
8.92714e-06
|
|
|
ENPP2
|
[NCBI]
|
8.78608e-06
|
|
|
MPO
|
[NCBI]
|
8.72361e-06
|
|
|
DAZL
|
[NCBI]
|
8.61719e-06
|
|
|
TNFSF15
|
[NCBI]
|
8.61719e-06
|
|
|
CXCL9
|
[NCBI]
|
8.61719e-06
|
|
|
MCOLN1
|
[NCBI]
|
8.61719e-06
|
|
|
NLRP3
|
[NCBI]
|
8.61719e-06
|
|
|
CD19
|
[NCBI]
|
8.61719e-06
|
|
|
PEX12
|
[NCBI]
|
8.61719e-06
|
|
|
PPBP
|
[NCBI]
|
8.61719e-06
|
|
|
TEK
|
[NCBI]
|
8.61719e-06
|
|
|
PDCD4
|
[NCBI]
|
8.61719e-06
|
|
|
FBLN1
|
[NCBI]
|
8.61719e-06
|
|
|
PEX1
|
[NCBI]
|
8.61719e-06
|
|
|
APOB
|
[NCBI]
|
8.53185e-06
|
|
|
TLR4
|
[NCBI]
|
8.37724e-06
|
|
|
RNASE3
|
[NCBI]
|
8.20025e-06
|
|
|
OPRM1
|
[NCBI]
|
8.04759e-06
|
|
|
UROS
|
[NCBI]
|
7.99147e-06
|
|
|
ONECUT1
|
[NCBI]
|
7.99147e-06
|
|
|
COL6A2
|
[NCBI]
|
7.99147e-06
|
|
|
CRP
|
[NCBI]
|
7.99147e-06
|
|
|
SGK
|
[NCBI]
|
7.99147e-06
|
|
|
GLI
|
[NCBI]
|
7.99147e-06
|
|
|
DHCR7
|
[NCBI]
|
7.99147e-06
|
|
|
PAPSS2
|
[NCBI]
|
7.99147e-06
|
|
|
HPS1
|
[NCBI]
|
7.99147e-06
|
|
|
MMP14
|
[NCBI]
|
7.99147e-06
|
|
|
SDHC
|
[NCBI]
|
7.99147e-06
|
|
|
GNB3
|
[NCBI]
|
7.99147e-06
|
|
|
HADH
|
[NCBI]
|
7.99147e-06
|
|
|
CBP2
|
[NCBI]
|
7.99147e-06
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
7.99147e-06
|
|
|
myxoma, intracardiac
|
[NCBI]
|
7.74311e-06
|
|
|
OCA2
|
[NCBI]
|
7.74311e-06
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
7.74311e-06
|
|
|
MVA
|
[NCBI]
|
7.74311e-06
|
|
|
ALMS
|
[NCBI]
|
7.74311e-06
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
7.74311e-06
|
|
|
SDC2
|
[NCBI]
|
7.56739e-06
|
|
|
CEACAM5
|
[NCBI]
|
7.55572e-06
|
|
|
GDNF
|
[NCBI]
|
7.5425e-06
|
|
|
CPT1A
|
[NCBI]
|
7.43152e-06
|
|
|
CD14
|
[NCBI]
|
7.43152e-06
|
|
|
GNPAT
|
[NCBI]
|
7.43152e-06
|
|
|
DSC2
|
[NCBI]
|
7.43152e-06
|
|
|
SCCA1
|
[NCBI]
|
7.43152e-06
|
|
|
PTS
|
[NCBI]
|
7.43152e-06
|
|
|
CYP11A1
|
[NCBI]
|
7.43152e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
7.43152e-06
|
|
|
CDSP
|
[NCBI]
|
7.31545e-06
|
|
|
CMT1A
|
[NCBI]
|
7.29872e-06
|
|
|
PGK1
|
[NCBI]
|
7.29834e-06
|
|
|
AOS
|
[NCBI]
|
7.1804e-06
|
|
|
FGF1
|
[NCBI]
|
7.10437e-06
|
|
|
ELN
|
[NCBI]
|
7.07735e-06
|
|
|
ARG1
|
[NCBI]
|
6.92633e-06
|
|
|
PZP
|
[NCBI]
|
6.92633e-06
|
|
|
PPOX
|
[NCBI]
|
6.92633e-06
|
|
|
MTND4L
|
[NCBI]
|
6.92633e-06
|
|
|
CTNNA1
|
[NCBI]
|
6.92633e-06
|
|
|
ME2
|
[NCBI]
|
6.92633e-06
|
|
|
FOXE1
|
[NCBI]
|
6.92633e-06
|
|
|
AL-A1
|
[NCBI]
|
6.92633e-06
|
|
|
RPS3
|
[NCBI]
|
6.92633e-06
|
|
|
ERBB4
|
[NCBI]
|
6.92633e-06
|
|
|
GALP
|
[NCBI]
|
6.86318e-06
|
|
|
PMCH
|
[NCBI]
|
6.80524e-06
|
|
|
GAPDH
|
[NCBI]
|
6.78935e-06
|
|
|
SHBG
|
[NCBI]
|
6.73337e-06
|
|
|
CDK4
|
[NCBI]
|
6.65258e-06
|
|
|
INAD1
|
[NCBI]
|
6.62129e-06
|
|
|
glycogen storage disease iii
|
[NCBI]
|
6.62129e-06
|
|
|
AIED
|
[NCBI]
|
6.62129e-06
|
|
|
SCN1
|
[NCBI]
|
6.62129e-06
|
|
|
ANTXR1
|
[NCBI]
|
6.46746e-06
|
|
|
RAB27A
|
[NCBI]
|
6.46746e-06
|
|
|
ERCC6
|
[NCBI]
|
6.46746e-06
|
|
|
EFNB2
|
[NCBI]
|
6.46746e-06
|
|
|
ACAT1
|
[NCBI]
|
6.46746e-06
|
|
|
NTRK3
|
[NCBI]
|
6.46746e-06
|
|
|
SOAT1
|
[NCBI]
|
6.46746e-06
|
|
|
PROS1
|
[NCBI]
|
6.46746e-06
|
|
|
CFH
|
[NCBI]
|
6.45413e-06
|
|
|
INS
|
[NCBI]
|
6.35064e-06
|
|
|
ADM
|
[NCBI]
|
6.27237e-06
|
|
|
GCCR
|
[NCBI]
|
6.25874e-06
|
|
|
homocystinuria
|
[NCBI]
|
6.06911e-06
|
|
|
wilson disease
|
[NCBI]
|
6.0512e-06
|
|
|
PCCA
|
[NCBI]
|
6.04827e-06
|
|
|
JUP
|
[NCBI]
|
6.04827e-06
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
6.04827e-06
|
|
|
SLC2A1
|
[NCBI]
|
6.04827e-06
|
|
|
DICER1
|
[NCBI]
|
6.04827e-06
|
|
|
NR3C2
|
[NCBI]
|
6.04827e-06
|
|
|
UBE1
|
[NCBI]
|
6.04827e-06
|
|
|
CLN3
|
[NCBI]
|
6.04827e-06
|
|
|
LEF1
|
[NCBI]
|
6.04827e-06
|
|
|
PXMP3
|
[NCBI]
|
6.04827e-06
|
|
|
CLDN1
|
[NCBI]
|
6.04827e-06
|
|
|
FGF2
|
[NCBI]
|
6.0173e-06
|
|
|
COMT
|
[NCBI]
|
5.88418e-06
|
|
|
CTSL
|
[NCBI]
|
5.70627e-06
|
|
|
MTND2
|
[NCBI]
|
5.66345e-06
|
|
|
CAMP
|
[NCBI]
|
5.66345e-06
|
|
|
CCL18
|
[NCBI]
|
5.66345e-06
|
|
|
GALK1
|
[NCBI]
|
5.66345e-06
|
|
|
FST
|
[NCBI]
|
5.66345e-06
|
|
|
CNR1
|
[NCBI]
|
5.66345e-06
|
|
|
MAPK9
|
[NCBI]
|
5.66345e-06
|
|
|
RCC1
|
[NCBI]
|
5.66345e-06
|
|
|
GCH1
|
[NCBI]
|
5.66345e-06
|
|
|
CCL19
|
[NCBI]
|
5.66345e-06
|
|
|
RELA
|
[NCBI]
|
5.66345e-06
|
|
|
MC2R
|
[NCBI]
|
5.66345e-06
|
|
|
HMOX1
|
[NCBI]
|
5.66345e-06
|
|
|
NPHS1
|
[NCBI]
|
5.63473e-06
|
|
|
AAA
|
[NCBI]
|
5.63473e-06
|
|
|
GACI
|
[NCBI]
|
5.63473e-06
|
|
|
CP
|
[NCBI]
|
5.59905e-06
|
|
|
HLA-A
|
[NCBI]
|
5.53265e-06
|
|
|
SOD1
|
[NCBI]
|
5.47598e-06
|
|
|
HEMB
|
[NCBI]
|
5.36396e-06
|
|
|
AT
|
[NCBI]
|
5.31225e-06
|
|
|
TGFBI
|
[NCBI]
|
5.30871e-06
|
|
|
PTGS1
|
[NCBI]
|
5.30871e-06
|
|
|
IL9
|
[NCBI]
|
5.30871e-06
|
|
|
RBP4
|
[NCBI]
|
5.30871e-06
|
|
|
GJB6
|
[NCBI]
|
5.30871e-06
|
|
|
GJB3
|
[NCBI]
|
5.30871e-06
|
|
|
CST3
|
[NCBI]
|
5.30871e-06
|
|
|
ALPL
|
[NCBI]
|
5.30871e-06
|
|
|
MVK
|
[NCBI]
|
5.30871e-06
|
|
|
ACE
|
[NCBI]
|
5.23182e-06
|
|
|
ILK
|
[NCBI]
|
5.11076e-06
|
|
|
ADA
|
[NCBI]
|
5.02529e-06
|
|
|
NEU1
|
[NCBI]
|
4.98049e-06
|
|
|
OPA1
|
[NCBI]
|
4.98049e-06
|
|
|
IL7R
|
[NCBI]
|
4.98049e-06
|
|
|
MTCO3
|
[NCBI]
|
4.98049e-06
|
|
|
LS
|
[NCBI]
|
4.9529e-06
|
|
|
PEDF
|
[NCBI]
|
4.81119e-06
|
|
|
LPG
|
[NCBI]
|
4.76649e-06
|
|
|
CGL2
|
[NCBI]
|
4.76649e-06
|
|
|
PPAC
|
[NCBI]
|
4.76649e-06
|
|
|
pfeiffer syndrome
|
[NCBI]
|
4.76649e-06
|
|
|
argininemia
|
[NCBI]
|
4.76649e-06
|
|
|
SLC18A3
|
[NCBI]
|
4.69264e-06
|
|
|
ERCC1
|
[NCBI]
|
4.67585e-06
|
|
|
MTCO2
|
[NCBI]
|
4.67585e-06
|
|
|
MTND3
|
[NCBI]
|
4.67585e-06
|
|
|
TERF2
|
[NCBI]
|
4.67585e-06
|
|
|
DLD
|
[NCBI]
|
4.67585e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
4.67585e-06
|
|
|
KL
|
[NCBI]
|
4.67585e-06
|
|
|
FUS
|
[NCBI]
|
4.67585e-06
|
|
|
PLAUR
|
[NCBI]
|
4.61448e-06
|
|
|
CEACAM1
|
[NCBI]
|
4.44631e-06
|
|
|
LCN2
|
[NCBI]
|
4.44631e-06
|
|
|
ENPP1
|
[NCBI]
|
4.39229e-06
|
|
|
MAP2K1
|
[NCBI]
|
4.39229e-06
|
|
|
MUT
|
[NCBI]
|
4.39229e-06
|
|
|
BRAF
|
[NCBI]
|
4.39229e-06
|
|
|
MAP4
|
[NCBI]
|
4.39229e-06
|
|
|
LCP1
|
[NCBI]
|
4.39229e-06
|
|
|
PEX7
|
[NCBI]
|
4.39229e-06
|
|
|
TGM2
|
[NCBI]
|
4.39229e-06
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
4.39229e-06
|
|
|
SLC25A20
|
[NCBI]
|
4.39229e-06
|
|
|
MTND5
|
[NCBI]
|
4.39229e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
4.30773e-06
|
|
|
phenylketonuria
|
[NCBI]
|
4.30773e-06
|
|
|
AIRE
|
[NCBI]
|
4.30773e-06
|
|
|
CHH
|
[NCBI]
|
4.15462e-06
|
|
|
COL4A5
|
[NCBI]
|
4.12772e-06
|
|
|
GSTP1
|
[NCBI]
|
4.12772e-06
|
|
|
NRP1
|
[NCBI]
|
4.12772e-06
|
|
|
GATA3
|
[NCBI]
|
4.12772e-06
|
|
|
MTND6
|
[NCBI]
|
4.12772e-06
|
|
|
C3
|
[NCBI]
|
4.12772e-06
|
|
|
TK1
|
[NCBI]
|
4.12772e-06
|
|
|
LCAT
|
[NCBI]
|
4.11139e-06
|
|
|
NOTCH1
|
[NCBI]
|
4.04168e-06
|
|
|
refsum disease
|
[NCBI]
|
4.00262e-06
|
|
|
gaucher disease, type iii
|
[NCBI]
|
4.00262e-06
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
4.00262e-06
|
|
|
maple syrup urine disease
|
[NCBI]
|
3.99982e-06
|
|
|
hypertension, essential
|
[NCBI]
|
3.99982e-06
|
|
|
LBP
|
[NCBI]
|
3.914e-06
|
|
|
MAPK8
|
[NCBI]
|
3.88031e-06
|
|
|
MSH2
|
[NCBI]
|
3.88031e-06
|
|
|
CCL25
|
[NCBI]
|
3.88031e-06
|
|
|
IGF2R
|
[NCBI]
|
3.88031e-06
|
|
|
HAS2
|
[NCBI]
|
3.88031e-06
|
|
|
TLR2
|
[NCBI]
|
3.82649e-06
|
|
|
ABCC1
|
[NCBI]
|
3.81009e-06
|
|
|
MEN2A
|
[NCBI]
|
3.80587e-06
|
|
|
ND
|
[NCBI]
|
3.80587e-06
|
|
|
APOE
|
[NCBI]
|
3.72336e-06
|
|
|
GALC
|
[NCBI]
|
3.6485e-06
|
|
|
DLK1
|
[NCBI]
|
3.6485e-06
|
|
|
MTCO1
|
[NCBI]
|
3.6485e-06
|
|
|
IL2RG
|
[NCBI]
|
3.6485e-06
|
|
|
FSTL3
|
[NCBI]
|
3.6485e-06
|
|
|
IFNGR1
|
[NCBI]
|
3.6485e-06
|
|
|
THRA
|
[NCBI]
|
3.6485e-06
|
|
|
ALB
|
[NCBI]
|
3.49741e-06
|
|
|
LMNA
|
[NCBI]
|
3.43635e-06
|
|
|
GSN
|
[NCBI]
|
3.43094e-06
|
|
|
TGFBR2
|
[NCBI]
|
3.43094e-06
|
|
|
TWIST1
|
[NCBI]
|
3.43094e-06
|
|
|
NOS2A
|
[NCBI]
|
3.43094e-06
|
|
|
CYP17A1
|
[NCBI]
|
3.43094e-06
|
|
|
CLN1
|
[NCBI]
|
3.33151e-06
|
|
|
CRYAB
|
[NCBI]
|
3.22644e-06
|
|
|
RECQL2
|
[NCBI]
|
3.22644e-06
|
|
|
ATP7A
|
[NCBI]
|
3.22644e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
3.16099e-06
|
|
|
ACADS
|
[NCBI]
|
3.03396e-06
|
|
|
CDC42
|
[NCBI]
|
3.03396e-06
|
|
|
IGHG1
|
[NCBI]
|
3.03396e-06
|
|
|
MTATP6
|
[NCBI]
|
3.03396e-06
|
|
|
DST
|
[NCBI]
|
3.03396e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
3.03396e-06
|
|
|
FH
|
[NCBI]
|
3.03396e-06
|
|
|
OSM
|
[NCBI]
|
2.96627e-06
|
|
|
CD44
|
[NCBI]
|
2.85256e-06
|
|
|
FY
|
[NCBI]
|
2.85256e-06
|
|
|
ACOX1
|
[NCBI]
|
2.85256e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
2.80917e-06
|
|
|
ALK
|
[NCBI]
|
2.75462e-06
|
|
|
HNA
|
[NCBI]
|
2.74338e-06
|
|
|
aHUS
|
[NCBI]
|
2.74338e-06
|
|
|
MNS
|
[NCBI]
|
2.74338e-06
|
|
|
EFE
|
[NCBI]
|
2.74338e-06
|
|
|
SEDC
|
[NCBI]
|
2.74338e-06
|
|
|
OCRL
|
[NCBI]
|
2.74338e-06
|
|
|
TGD
|
[NCBI]
|
2.74338e-06
|
|
|
MEN2B
|
[NCBI]
|
2.74338e-06
|
|
|
AGER
|
[NCBI]
|
2.72939e-06
|
|
|
XPA
|
[NCBI]
|
2.68143e-06
|
|
|
SOX10
|
[NCBI]
|
2.68143e-06
|
|
|
TLR7
|
[NCBI]
|
2.68143e-06
|
|
|
PPARA
|
[NCBI]
|
2.59581e-06
|
|
|
TFPI2
|
[NCBI]
|
2.51984e-06
|
|
|
MTR
|
[NCBI]
|
2.51984e-06
|
|
|
IGF1R
|
[NCBI]
|
2.51984e-06
|
|
|
IL12B
|
[NCBI]
|
2.51984e-06
|
|
|
AQP5
|
[NCBI]
|
2.51984e-06
|
|
|
ICAM1
|
[NCBI]
|
2.51984e-06
|
|
|
LPI
|
[NCBI]
|
2.45854e-06
|
|
|
MTND4
|
[NCBI]
|
2.36711e-06
|
|
|
FN1
|
[NCBI]
|
2.36711e-06
|
|
|
AREG
|
[NCBI]
|
2.36711e-06
|
|
|
STAT5B
|
[NCBI]
|
2.36711e-06
|
|
|
VIP
|
[NCBI]
|
2.34999e-06
|
|
|
HGF
|
[NCBI]
|
2.28607e-06
|
|
|
APS1
|
[NCBI]
|
2.23858e-06
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
2.22993e-06
|
|
|
OFD1
|
[NCBI]
|
2.22993e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
2.22993e-06
|
|
|
CDKN1A
|
[NCBI]
|
2.22267e-06
|
|
|
TNFSF13B
|
[NCBI]
|
2.22267e-06
|
|
|
MMP3
|
[NCBI]
|
2.22267e-06
|
|
|
GAMT
|
[NCBI]
|
2.22267e-06
|
|
|
PPARG
|
[NCBI]
|
2.19341e-06
|
|
|
HEXB
|
[NCBI]
|
2.08598e-06
|
|
|
USF1
|
[NCBI]
|
2.08598e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.03354e-06
|
|
|
JMML
|
[NCBI]
|
1.96403e-06
|
|
|
ABCA1
|
[NCBI]
|
1.95656e-06
|
|
|
GLB1
|
[NCBI]
|
1.95656e-06
|
|
|
CXCL12
|
[NCBI]
|
1.95656e-06
|
|
|
SOCS1
|
[NCBI]
|
1.95656e-06
|
|
|
PPT1
|
[NCBI]
|
1.95656e-06
|
|
|
IL8
|
[NCBI]
|
1.95656e-06
|
|
|
MTCYB
|
[NCBI]
|
1.95656e-06
|
|
|
PLK1
|
[NCBI]
|
1.92838e-06
|
|
|
IL5
|
[NCBI]
|
1.83395e-06
|
|
|
UGCG
|
[NCBI]
|
1.83395e-06
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
1.78404e-06
|
|
|
FPLD2
|
[NCBI]
|
1.78404e-06
|
|
|
ARSA
|
[NCBI]
|
1.71777e-06
|
|
|
HRG
|
[NCBI]
|
1.71777e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
1.7038e-06
|
|
|
HIF1A
|
[NCBI]
|
1.60765e-06
|
|
|
TSC2
|
[NCBI]
|
1.60765e-06
|
|
|
SVAS
|
[NCBI]
|
1.58907e-06
|
|
|
SMAX1
|
[NCBI]
|
1.51559e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.50324e-06
|
|
|
MTND1
|
[NCBI]
|
1.50324e-06
|
|
|
FABP3
|
[NCBI]
|
1.50324e-06
|
|
|
CDK2
|
[NCBI]
|
1.49961e-06
|
|
|
FGFR3
|
[NCBI]
|
1.46753e-06
|
|
|
TACR1
|
[NCBI]
|
1.40424e-06
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
1.39955e-06
|
|
|
CPX
|
[NCBI]
|
1.39955e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.34786e-06
|
|
|
kabuki syndrome
|
[NCBI]
|
1.34336e-06
|
|
|
ESD
|
[NCBI]
|
1.31725e-06
|
|
|
MAPK14
|
[NCBI]
|
1.31037e-06
|
|
|
TERT
|
[NCBI]
|
1.28197e-06
|
|
|
MAP3K5
|
[NCBI]
|
1.28197e-06
|
|
|
IL4
|
[NCBI]
|
1.26208e-06
|
|
|
DSTN
|
[NCBI]
|
1.22135e-06
|
|
|
PLP1
|
[NCBI]
|
1.22135e-06
|
|
|
HRAS
|
[NCBI]
|
1.22135e-06
|
|
|
RB1
|
[NCBI]
|
1.16743e-06
|
|
|
MST1
|
[NCBI]
|
1.13696e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
1.07114e-06
|
|
|
OPA1
|
[NCBI]
|
1.07114e-06
|
|
|
fraser syndrome
|
[NCBI]
|
1.07114e-06
|
|
|
IL10
|
[NCBI]
|
1.05696e-06
|
|
|
ZNF145
|
[NCBI]
|
1.05696e-06
|
|
|
BTHS
|
[NCBI]
|
1.01601e-06
|
|
|
AKT1
|
[NCBI]
|
9.8114e-07
|
|
|
CSF2
|
[NCBI]
|
9.8114e-07
|
|
|
KDR
|
[NCBI]
|
9.7554e-07
|
|
|
PC
|
[NCBI]
|
9.62805e-07
|
|
|
TNF
|
[NCBI]
|
9.32096e-07
|
|
|
PROCR
|
[NCBI]
|
9.09312e-07
|
|
|
ITGB3
|
[NCBI]
|
9.09312e-07
|
|
|
TP53
|
[NCBI]
|
9.09012e-07
|
|
|
THRB
|
[NCBI]
|
8.41292e-07
|
|
|
GRIA1
|
[NCBI]
|
8.41292e-07
|
|
|
PNMT
|
[NCBI]
|
8.35606e-07
|
|
|
CRMO
|
[NCBI]
|
8.20272e-07
|
|
|
CMT1B
|
[NCBI]
|
8.20272e-07
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
8.20272e-07
|
|
|
SCIDX1
|
[NCBI]
|
8.20272e-07
|
|
|
SGBS1
|
[NCBI]
|
7.94113e-07
|
|
|
OCA1A
|
[NCBI]
|
7.94113e-07
|
|
|
SLC6A6
|
[NCBI]
|
7.7691e-07
|
|
|
CHS
|
[NCBI]
|
7.48494e-07
|
|
|
PTN
|
[NCBI]
|
7.13477e-07
|
|
|
GSR
|
[NCBI]
|
6.5844e-07
|
|
|
campomelic dysplasia
|
[NCBI]
|
6.42715e-07
|
|
|
MBL2
|
[NCBI]
|
6.37058e-07
|
|
|
CALCRL
|
[NCBI]
|
6.0582e-07
|
|
|
CCL21
|
[NCBI]
|
6.04065e-07
|
|
|
DKC
|
[NCBI]
|
5.64367e-07
|
|
|
RBS
|
[NCBI]
|
5.64367e-07
|
|
|
HD
|
[NCBI]
|
5.56734e-07
|
|
|
MTTL1
|
[NCBI]
|
5.52752e-07
|
|
|
MITF
|
[NCBI]
|
5.39933e-07
|
|
|
GAL
|
[NCBI]
|
4.99943e-07
|
|
|
down syndrome
|
[NCBI]
|
4.84301e-07
|
|
|
ABCB1
|
[NCBI]
|
4.78562e-07
|
|
|
LRP1
|
[NCBI]
|
4.57958e-07
|
|
|
hemophilia a
|
[NCBI]
|
4.16004e-07
|
|
|
SLOS
|
[NCBI]
|
4.12295e-07
|
|
|
VIM
|
[NCBI]
|
4.07654e-07
|
|
|
TNFSF6
|
[NCBI]
|
3.99435e-07
|
|
|
NPM1
|
[NCBI]
|
3.81877e-07
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
3.78261e-07
|
|
|
SLC18A2
|
[NCBI]
|
3.75788e-07
|
|
|
GNAS
|
[NCBI]
|
3.75788e-07
|
|
|
COL2A1
|
[NCBI]
|
3.75788e-07
|
|
|
PF4
|
[NCBI]
|
3.71581e-07
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
3.46064e-07
|
|
|
CTNS
|
[NCBI]
|
3.46064e-07
|
|
|
PTEN
|
[NCBI]
|
3.32396e-07
|
|
|
JAK2
|
[NCBI]
|
3.28588e-07
|
|
|
APRT
|
[NCBI]
|
3.13582e-07
|
|
|
GJA1
|
[NCBI]
|
3.05171e-07
|
|
|
GHR
|
[NCBI]
|
2.9375e-07
|
|
|
INSR
|
[NCBI]
|
2.85768e-07
|
|
|
HNF1A
|
[NCBI]
|
2.39205e-07
|
|
|
CTNNB1
|
[NCBI]
|
2.39205e-07
|
|
|
RIEG1
|
[NCBI]
|
2.32562e-07
|
|
|
galactosemia
|
[NCBI]
|
2.29123e-07
|
|
|
HP
|
[NCBI]
|
2.14274e-07
|
|
|
ATF3
|
[NCBI]
|
2.10707e-07
|
|
|
CAT
|
[NCBI]
|
2.06391e-07
|
|
|
PMP22
|
[NCBI]
|
1.85634e-07
|
|
|
BTC
|
[NCBI]
|
1.84315e-07
|
|
|
STAT3
|
[NCBI]
|
1.60998e-07
|
|
|
DBI
|
[NCBI]
|
1.47688e-07
|
|
|
FOP
|
[NCBI]
|
1.34695e-07
|
|
|
NF2
|
[NCBI]
|
1.24383e-07
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
1.24383e-07
|
|
|
UBTF
|
[NCBI]
|
1.17084e-07
|
|
|
PARP1
|
[NCBI]
|
1.17084e-07
|
|
|
DDC
|
[NCBI]
|
1.14591e-07
|
|
|
COMP
|
[NCBI]
|
1.02746e-07
|
|
|
IGFALS
|
[NCBI]
|
9.84449e-08
|
|
|
KITLG
|
[NCBI]
|
9.01342e-08
|
|
|
MPZ
|
[NCBI]
|
8.15922e-08
|
|
|
IFNA1
|
[NCBI]
|
8.15922e-08
|
|
|
IDE
|
[NCBI]
|
7.30594e-08
|
|
|
VASP
|
[NCBI]
|
7.18409e-08
|
|
|
RTS
|
[NCBI]
|
6.41043e-08
|
|
|
PTGS2
|
[NCBI]
|
6.11129e-08
|
|
|
SOCS3
|
[NCBI]
|
5.303e-08
|
|
|
breast cancer
|
[NCBI]
|
5.11352e-08
|
|
|
ATM
|
[NCBI]
|
5.01522e-08
|
|
|
AKR1B1
|
[NCBI]
|
4.39434e-08
|
|
|
F2R
|
[NCBI]
|
3.09871e-08
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
1.87947e-08
|
|
|
SRY
|
[NCBI]
|
1.09861e-08
|
|
|
LPO
|
[NCBI]
|
1.09861e-08
|
|
|
APP
|
[NCBI]
|
2.06438e-09
|
|
|
STAT6
|
[NCBI]
|
2.01624e-09
|
|
|
G6PD
|
[NCBI]
|
1.44422e-09
|
|
|
MCP
|
[NCBI]
|
7.52873e-10
|
|
|
HFE
|
[NCBI]
|
3.45569e-11
|
|